R.M. Davis Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.2M Sell
281,324
-160
-0.1% -$12.9K 0.35% 66
2026
Q1
$24.6M Buy
281,484
+11,040
+4% +$1.06M 0.44% 65
2025
Q4
$26M Buy
270,444
+2,854
+1% +$277K 0.45% 63
2025
Q3
$25.5M Buy
267,590
+4,463
+2% +$410K 0.45% 63
2025
Q2
$22.9M Sell
263,127
-1,130
-0.4% -$95.8K 0.43% 66
2025
Q1
$23.7M Sell
264,257
-1,475
-0.6% -$132K 0.48% 60
2024
Q4
$21.2M Sell
265,732
-1,664
-0.6% -$144K 0.41% 65
2024
Q3
$24.1M Sell
267,396
-8,555
-3% -$720K 0.47% 65
2024
Q2
$21.7M Buy
275,951
+2,136
+0.8% +$175K 0.44% 66
2024
Q1
$23.9M Buy
273,815
+10,458
+4% +$893K 0.5% 63
2023
Q4
$21.7M Sell
263,357
-11,272
-4% -$859K 0.5% 64
2023
Q3
$21.5M Sell
274,629
-2,018
-0.7% -$169K 0.54% 63
2023
Q2
$24.4M Sell
276,647
-1,703
-0.6% -$147K 0.59% 61
2023
Q1
$22.4M Buy
278,350
+4,475
+2% +$365K 0.57% 61
2022
Q4
$21.3M Sell
273,875
-11,454
-4% -$928K 0.57% 61
2022
Q3
$23M Sell
285,329
-1,558
-0.5% -$140K 0.67% 55
2022
Q2
$25.7M Sell
286,887
-3,752
-1% -$380K 0.72% 54
2022
Q1
$32.2M Buy
290,639
+2,538
+0.9% +$268K 0.77% 46
2021
Q4
$29.8M Buy
288,101
+5,633
+2% +$652K 0.66% 54
2021
Q3
$35.4M Sell
282,468
-2,215
-0.8% -$287K 0.88% 44
2021
Q2
$35.3M Sell
284,683
-7,422
-3% -$932K 0.89% 44
2021
Q1
$34.5M Sell
292,105
-22,594
-7% -$2.65M 0.95% 40
2020
Q4
$36.9M Sell
314,699
-12,141
-4% -$1.34M 1.06% 36
2020
Q3
$34M Sell
326,840
-4,776
-1% -$480K 1.11% 32
2020
Q2
$30.4M Sell
331,616
-9,408
-3% -$902K 1.08% 34
2020
Q1
$30.8M Sell
341,024
-1,225
-0.4% -$130K 1.28% 31
2019
Q4
$38.8M Sell
342,249
-892
-0.3% -$97.9K 1.27% 31
2019
Q3
$37.3M Sell
343,141
-1,491
-0.4% -$156K 1.31% 32
2019
Q2
$33.6M Buy
344,632
+532
+0.2% +$48.6K 1.19% 34
2019
Q1
$31.3M Sell
344,100
-9,637
-3% -$863K 1.17% 36
2018
Q4
$32.2M Buy
353,737
+800
+0.2% +$74.8K 1.32% 32
2018
Q3
$34.7M Sell
352,937
-3,200
-0.9% -$296K 1.26% 32
2018
Q2
$30.5M Sell
356,137
-15,760
-4% -$1.32M 1.19% 36
2018
Q1
$29.8M Sell
371,897
-6,775
-2% -$559K 1.19% 39
2017
Q4
$30.6M Sell
378,672
-7,924
-2% -$635K 1.2% 38
2017
Q3
$30.1M Sell
386,596
-7,626
-2% -$633K 1.24% 35
2017
Q2
$35M Sell
394,222
-7,969
-2% -$672K 1.48% 23
2017
Q1
$32.4M Sell
402,191
-4,727
-1% -$369K 1.46% 23
2016
Q4
$29M Buy
406,918
+7,649
+2% +$601K 1.39% 28
2016
Q3
$34.5M Buy
399,269
+307
+0.1% +$26.8K 1.68% 17
2016
Q2
$34.6M Sell
398,962
-9,151
-2% -$740K 1.7% 15
2016
Q1
$30.6M Buy
408,113
+3,968
+1% +$299K 1.56% 21
2015
Q4
$31.1M Buy
404,145
+6,118
+2% +$461K 1.59% 20
2015
Q3
$26.6M Buy
398,027
+14,248
+4% +$1.05M 1.42% 26
2015
Q2
$28.4M Buy
383,779
+21,994
+6% +$1.68M 1.47% 26
2015
Q1
$28.2M Buy
361,785
+351,012
+3,258% +$26.6M 1.48% 26
2014
Q4
$778K Sell
10,773
-894
-8% -$62.1K 0.04% 128
2014
Q3
$723K Buy
+11,667
New +$742K 0.04% 125

Other funds holding MDT

R.M. Davis Inc's MDT Position: Q2 2026 in Review

R.M. Davis Inc reduced its Medtronic (MDT) stake by 0.06% in Q2 2026, selling an estimated $12.9K and leaving 281,324 shares worth $22.2M. The position accounts for 0.35% of the portfolio, ranked #66.

R.M. Davis Inc first reported a position in MDT in Q3 2014 and has held it in 48 quarters since. The position peaked at $38.8M in Q4 2019. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • R.M. Davis Inc held 281,324 shares of Medtronic worth $22.2M as of Q2 2026.
  • R.M. Davis Inc sold 160 Medtronic shares in Q2 2026, an estimated $12.9K.
  • Medtronic made up 0.35% of R.M. Davis Inc's portfolio in Q2 2026, its #66 holding.
  • R.M. Davis Inc first reported a position in Medtronic in Q3 2014 and has held it in 48 quarters since.
  • R.M. Davis Inc's Medtronic position peaked at $38.8M in Q4 2019.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.